APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Cold and Cough Medicines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global OTC Cold and Cough Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025190 pages

Choose your research edition.

Industry ResearchOTC Cold and Cough Medicines Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Cold and Cough Medicines Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal OTC Cold and Cough Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Cold and Cough Medicines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Cold and Cough Medicines Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global OTC Cold and Cough Medicines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for OTC Cold and Cough Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Cold and Cough Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Cold and Cough Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for OTC Cold and Cough Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of OTC Cold and Cough Medicines include Sun Pharmaceutical, Johnson & Johnson, Novartis AG, Pfizer Inc., GlaxoSmithKline Plc., Sanofi-Aventis, Reckitt Benckiser Group Plc., Procter & Gamble Co. and Prestige Brands Holdings, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global OTC Cold and Cough Medicines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Cold and Cough Medicines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Cold and Cough Medicines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the OTC Cold and Cough Medicines market size, projected growth trends, production technologies, key applications, and end-use industries.

OTC Cold and Cough Medicines Segment by Company

Sun Pharmaceutical

Johnson & Johnson

Novartis AG

Pfizer Inc.

GlaxoSmithKline Plc.

Sanofi-Aventis

Reckitt Benckiser Group Plc.

Procter & Gamble Co.

Prestige Brands Holdings, Inc.

AstraZeneca Plc.

OTC Cold and Cough Medicines Segment by Type

Drops

Powders

Capsules

Sprays

Tablets

Pellets

OTC Cold and Cough Medicines Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

OTC Cold and Cough Medicines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Cold and Cough Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Cold and Cough Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Cold and Cough Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the OTC Cold and Cough Medicines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of OTC Cold and Cough Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of OTC Cold and Cough Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of OTC Cold and Cough Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. OTC Cold and Cough Medicines Industry Trends Table 2. OTC Cold and Cough Medicines Industry Drivers Table 3. OTC Cold and Cough Medicines Industry Opportunities and Challenges Table 4. OTC Cold and Cough Medicines Industry Restraints Table 5. Global OTC Cold and Cough Medicines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global OTC Cold and Cough Medicines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global OTC Cold and Cough Medicines Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global OTC Cold and Cough Medicines Sales Market Share by Manufacturers Table 9. Global OTC Cold and Cough Medicines Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global OTC Cold and Cough Medicines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global OTC Cold and Cough Medicines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global OTC Cold and Cough Medicines Manufacturers, Product Type & Application Table 13. Global OTC Cold and Cough Medicines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global OTC Cold and Cough Medicines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Drops Table 17. Major Manufacturers of Powders Table 18. Major Manufacturers of Capsules Table 19. Major Manufacturers of Sprays Table 20. Major Manufacturers of Tablets Table 21. Major Manufacturers of Pellets Table 22. Global OTC Cold and Cough Medicines Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global OTC Cold and Cough Medicines Sales by Type (2021-2026) & (K Units) Table 24. Global OTC Cold and Cough Medicines Sales by Type (2027-2032) & (K Units) Table 25. Global OTC Cold and Cough Medicines Sales Market Share by Type (2021-2026) Table 26. Global OTC Cold and Cough Medicines Sales Market Share by Type (2027-2032) Table 27. Global OTC Cold and Cough Medicines Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global OTC Cold and Cough Medicines Revenue by Type (2021-2026) & (K Units) Table 29. Global OTC Cold and Cough Medicines Revenue by Type (2027-2032) & (K Units) Table 30. Global OTC Cold and Cough Medicines Revenue Market Share by Type (2021-2026) Table 31. Global OTC Cold and Cough Medicines Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Hospital Pharmacies Table 33. Major Manufacturers of Online Pharmacies Table 34. Major Manufacturers of Retail Pharmacies Table 35. Global OTC Cold and Cough Medicines Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global OTC Cold and Cough Medicines Sales by Application (2021-2026) & (K Units) Table 37. Global OTC Cold and Cough Medicines Sales by Application (2027-2032) & (K Units) Table 38. Global OTC Cold and Cough Medicines Sales Market Share by Application (2021-2026) Table 39. Global OTC Cold and Cough Medicines Sales Market Share by Application (2027-2032) Table 40. Global OTC Cold and Cough Medicines Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global OTC Cold and Cough Medicines Revenue by Application (2021-2026) & (K Units) Table 42. Global OTC Cold and Cough Medicines Revenue by Application (2027-2032) & (K Units) Table 43. Global OTC Cold and Cough Medicines Revenue Market Share by Application (2021-2026) Table 44. Global OTC Cold and Cough Medicines Revenue Market Share by Application (2027-2032) Table 45. Global OTC Cold and Cough Medicines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global OTC Cold and Cough Medicines Sales by Region (2021-2026) & (K Units) Table 47. Global OTC Cold and Cough Medicines Sales Market Share by Region (2021-2026) Table 48. Global OTC Cold and Cough Medicines Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global OTC Cold and Cough Medicines Sales Forecasted Market Share by Region (2027-2032) Table 50. North America OTC Cold and Cough Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America OTC Cold and Cough Medicines Sales by Country (2021-2026) & (K Units) Table 52. North America OTC Cold and Cough Medicines Sales by Country (2027-2032) & (K Units) Table 53. Europe OTC Cold and Cough Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe OTC Cold and Cough Medicines Sales by Country (2021-2026) & (K Units) Table 55. Europe OTC Cold and Cough Medicines Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific OTC Cold and Cough Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific OTC Cold and Cough Medicines Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific OTC Cold and Cough Medicines Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa OTC Cold and Cough Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa OTC Cold and Cough Medicines Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa OTC Cold and Cough Medicines Sales by Country (2027-2032) & (K Units) Table 62. Global OTC Cold and Cough Medicines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global OTC Cold and Cough Medicines Revenue by Region (2021-2026) & (US$ Million) Table 64. Global OTC Cold and Cough Medicines Revenue by Region (2027-2032) & (US$ Million) Table 65. Global OTC Cold and Cough Medicines Revenue Market Share by Region (2021-2026) Table 66. Global OTC Cold and Cough Medicines Revenue Market Share by Region (2027-2032) Table 67. Sun Pharmaceutical Company Information Table 68. Sun Pharmaceutical Business Overview Table 69. Sun Pharmaceutical OTC Cold and Cough Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Sun Pharmaceutical OTC Cold and Cough Medicines Product Portfolio Table 71. Sun Pharmaceutical Recent Development Table 72. Johnson & Johnson Company Information Table 73. Johnson & Johnson Business Overview Table 74. Johnson & Johnson OTC Cold and Cough Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Johnson & Johnson OTC Cold and Cough Medicines Product Portfolio Table 76. Johnson & Johnson Recent Development Table 77. Novartis AG Company Information Table 78. Novartis AG Business Overview Table 79. Novartis AG OTC Cold and Cough Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Novartis AG OTC Cold and Cough Medicines Product Portfolio Table 81. Novartis AG Recent Development Table 82. Pfizer Inc. Company Information Table 83. Pfizer Inc. Business Overview Table 84. Pfizer Inc. OTC Cold and Cough Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Pfizer Inc. OTC Cold and Cough Medicines Product Portfolio Table 86. Pfizer Inc. Recent Development Table 87. GlaxoSmithKline Plc. Company Information Table 88. GlaxoSmithKline Plc. Business Overview Table 89. GlaxoSmithKline Plc. OTC Cold and Cough Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. GlaxoSmithKline Plc. OTC Cold and Cough Medicines Product Portfolio Table 91. GlaxoSmithKline Plc. Recent Development Table 92. Sanofi-Aventis Company Information Table 93. Sanofi-Aventis Business Overview Table 94. Sanofi-Aventis OTC Cold and Cough Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Sanofi-Aventis OTC Cold and Cough Medicines Product Portfolio Table 96. Sanofi-Aventis Recent Development Table 97. Reckitt Benckiser Group Plc. Company Information Table 98. Reckitt Benckiser Group Plc. Business Overview Table 99. Reckitt Benckiser Group Plc. OTC Cold and Cough Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Reckitt Benckiser Group Plc. OTC Cold and Cough Medicines Product Portfolio Table 101. Reckitt Benckiser Group Plc. Recent Development Table 102. Procter & Gamble Co. Company Information Table 103. Procter & Gamble Co. Business Overview Table 104. Procter & Gamble Co. OTC Cold and Cough Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Procter & Gamble Co. OTC Cold and Cough Medicines Product Portfolio Table 106. Procter & Gamble Co. Recent Development Table 107. Prestige Brands Holdings, Inc. Company Information Table 108. Prestige Brands Holdings, Inc. Business Overview Table 109. Prestige Brands Holdings, Inc. OTC Cold and Cough Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Prestige Brands Holdings, Inc. OTC Cold and Cough Medicines Product Portfolio Table 111. Prestige Brands Holdings, Inc. Recent Development Table 112. AstraZeneca Plc. Company Information Table 113. AstraZeneca Plc. Business Overview Table 114. AstraZeneca Plc. OTC Cold and Cough Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. AstraZeneca Plc. OTC Cold and Cough Medicines Product Portfolio Table 116. AstraZeneca Plc. Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. OTC Cold and Cough Medicines Distributors List Table 120. OTC Cold and Cough Medicines Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. OTC Cold and Cough Medicines Product Image Figure 2. Global OTC Cold and Cough Medicines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Cold and Cough Medicines Market Size (2021-2032) & (US$ Million) Figure 4. Global OTC Cold and Cough Medicines Sales (2021-2032) & (K Units) Figure 5. Global OTC Cold and Cough Medicines Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 OTC Cold and Cough Medicines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Drops Image Figure 9. Powders Image Figure 10. Capsules Image Figure 11. Sprays Image Figure 12. Tablets Image Figure 13. Pellets Image Figure 14. Global OTC Cold and Cough Medicines Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global OTC Cold and Cough Medicines Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global OTC Cold and Cough Medicines Sales Market Share by Type (2021-2032) Figure 17. Global OTC Cold and Cough Medicines Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global OTC Cold and Cough Medicines Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global OTC Cold and Cough Medicines Revenue Market Share by Type (2021-2032) Figure 20. Hospital Pharmacies Image Figure 21. Online Pharmacies Image Figure 22. Retail Pharmacies Image Figure 23. Global OTC Cold and Cough Medicines Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global OTC Cold and Cough Medicines Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global OTC Cold and Cough Medicines Sales Market Share by Application (2021-2032) Figure 26. Global OTC Cold and Cough Medicines Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global OTC Cold and Cough Medicines Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global OTC Cold and Cough Medicines Revenue Market Share by Application (2021-2032) Figure 29. North America OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America OTC Cold and Cough Medicines Sales Market Share by Country (2021-2032) Figure 31. U.S. OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe OTC Cold and Cough Medicines Sales Market Share by Country (2021-2032) Figure 36. Germany OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific OTC Cold and Cough Medicines Sales Market Share by Country (2021-2032) Figure 43. China OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa OTC Cold and Cough Medicines Sales Market Share by Country (2021-2032) Figure 51. Brazil OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile OTC Cold and Cough Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global OTC Cold and Cough Medicines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global OTC Cold and Cough Medicines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America OTC Cold and Cough Medicines Revenue (2021-2032) & (US$ Million) Figure 62. North America OTC Cold and Cough Medicines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe OTC Cold and Cough Medicines Revenue (2021-2032) & (US$ Million) Figure 64. Europe OTC Cold and Cough Medicines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific OTC Cold and Cough Medicines Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific OTC Cold and Cough Medicines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa OTC Cold and Cough Medicines Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa OTC Cold and Cough Medicines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. OTC Cold and Cough Medicines Value Chain Figure 70. Manufacturing Cost Structure Figure 71. OTC Cold and Cough Medicines Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Drops
  • Powders
  • Capsules
  • Sprays
  • Tablets
  • Pellets
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Sun Pharmaceutical
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • GlaxoSmithKline Plc.
  • Sanofi-Aventis
  • Reckitt Benckiser Group Plc.
  • Procter & Gamble Co.
  • Prestige Brands Holdings, Inc.
  • AstraZeneca Plc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global OTC Cold and Cough Medicines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global OTC Cold and Cough Medicines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global OTC Cold and Cough Medicines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global OTC Cold and Cough Medicines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global OTC Cold and Cough Medicines Market Dynamics
  1. 2.1 OTC Cold and Cough Medicines Industry Trends
  2. 2.2 OTC Cold and Cough Medicines Industry Drivers
  3. 2.3 OTC Cold and Cough Medicines Industry Opportunities and Challenges
  4. 2.4 OTC Cold and Cough Medicines Industry Restraints
3 OTC Cold and Cough Medicines Market by Manufacturers
  1. 3.1 Global OTC Cold and Cough Medicines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global OTC Cold and Cough Medicines Sales by Manufacturers (2021-2026)
  3. 3.3 Global OTC Cold and Cough Medicines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global OTC Cold and Cough Medicines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global OTC Cold and Cough Medicines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global OTC Cold and Cough Medicines Manufacturers, Product Type & Application
  7. 3.7 Global OTC Cold and Cough Medicines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global OTC Cold and Cough Medicines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 OTC Cold and Cough Medicines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 OTC Cold and Cough Medicines Tier 1, Tier 2, and Tier 3
4 OTC Cold and Cough Medicines Market by Type
  1. 4.1 OTC Cold and Cough Medicines Type Introduction
  2. 4.1.1 Drops
  3. 4.1.2 Powders
  4. 4.1.3 Capsules
  5. 4.1.4 Sprays
  6. 4.1.5 Tablets
  7. 4.1.6 Pellets
  8. 4.2 Global OTC Cold and Cough Medicines Sales by Type
  9. 4.2.1 Global OTC Cold and Cough Medicines Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global OTC Cold and Cough Medicines Sales by Type (2021-2032)
  11. 4.2.3 Global OTC Cold and Cough Medicines Sales Market Share by Type (2021-2032)
  12. 4.3 Global OTC Cold and Cough Medicines Revenue by Type
  13. 4.3.1 Global OTC Cold and Cough Medicines Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global OTC Cold and Cough Medicines Revenue by Type (2021-2032)
  15. 4.3.3 Global OTC Cold and Cough Medicines Revenue Market Share by Type (2021-2032)
5 OTC Cold and Cough Medicines Market by Application
  1. 5.1 OTC Cold and Cough Medicines Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global OTC Cold and Cough Medicines Sales by Application
  6. 5.2.1 Global OTC Cold and Cough Medicines Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global OTC Cold and Cough Medicines Sales by Application (2021-2032)
  8. 5.2.3 Global OTC Cold and Cough Medicines Sales Market Share by Application (2021-2032)
  9. 5.3 Global OTC Cold and Cough Medicines Revenue by Application
  10. 5.3.1 Global OTC Cold and Cough Medicines Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global OTC Cold and Cough Medicines Revenue by Application (2021-2032)
  12. 5.3.3 Global OTC Cold and Cough Medicines Revenue Market Share by Application (2021-2032)
6 Global OTC Cold and Cough Medicines Sales by Region
  1. 6.1 Global OTC Cold and Cough Medicines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global OTC Cold and Cough Medicines Sales by Region (2021-2032)
  3. 6.2.1 Global OTC Cold and Cough Medicines Sales by Region (2021-2026)
  4. 6.2.2 Global OTC Cold and Cough Medicines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America OTC Cold and Cough Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America OTC Cold and Cough Medicines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe OTC Cold and Cough Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe OTC Cold and Cough Medicines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific OTC Cold and Cough Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific OTC Cold and Cough Medicines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa OTC Cold and Cough Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa OTC Cold and Cough Medicines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global OTC Cold and Cough Medicines Revenue by Region
  1. 7.1 Global OTC Cold and Cough Medicines Revenue by Region
  2. 7.1.1 Global OTC Cold and Cough Medicines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global OTC Cold and Cough Medicines Revenue by Region (2021-2026)
  4. 7.1.3 Global OTC Cold and Cough Medicines Revenue by Region (2027-2032)
  5. 7.1.4 Global OTC Cold and Cough Medicines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America OTC Cold and Cough Medicines Revenue (2021-2032)
  8. 7.2.2 North America OTC Cold and Cough Medicines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe OTC Cold and Cough Medicines Revenue (2021-2032)
  11. 7.3.2 Europe OTC Cold and Cough Medicines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific OTC Cold and Cough Medicines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific OTC Cold and Cough Medicines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa OTC Cold and Cough Medicines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa OTC Cold and Cough Medicines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical
  2. 8.1.1 Sun Pharmaceutical Company Information
  3. 8.1.2 Sun Pharmaceutical Business Overview
  4. 8.1.3 Sun Pharmaceutical OTC Cold and Cough Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical OTC Cold and Cough Medicines Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson OTC Cold and Cough Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson OTC Cold and Cough Medicines Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis AG
  14. 8.3.1 Novartis AG Company Information
  15. 8.3.2 Novartis AG Business Overview
  16. 8.3.3 Novartis AG OTC Cold and Cough Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis AG OTC Cold and Cough Medicines Product Portfolio
  18. 8.3.5 Novartis AG Recent Developments
  19. 8.4 Pfizer Inc.
  20. 8.4.1 Pfizer Inc. Company Information
  21. 8.4.2 Pfizer Inc. Business Overview
  22. 8.4.3 Pfizer Inc. OTC Cold and Cough Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Inc. OTC Cold and Cough Medicines Product Portfolio
  24. 8.4.5 Pfizer Inc. Recent Developments
  25. 8.5 GlaxoSmithKline Plc.
  26. 8.5.1 GlaxoSmithKline Plc. Company Information
  27. 8.5.2 GlaxoSmithKline Plc. Business Overview
  28. 8.5.3 GlaxoSmithKline Plc. OTC Cold and Cough Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Plc. OTC Cold and Cough Medicines Product Portfolio
  30. 8.5.5 GlaxoSmithKline Plc. Recent Developments
  31. 8.6 Sanofi-Aventis
  32. 8.6.1 Sanofi-Aventis Company Information
  33. 8.6.2 Sanofi-Aventis Business Overview
  34. 8.6.3 Sanofi-Aventis OTC Cold and Cough Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi-Aventis OTC Cold and Cough Medicines Product Portfolio
  36. 8.6.5 Sanofi-Aventis Recent Developments
  37. 8.7 Reckitt Benckiser Group Plc.
  38. 8.7.1 Reckitt Benckiser Group Plc. Company Information
  39. 8.7.2 Reckitt Benckiser Group Plc. Business Overview
  40. 8.7.3 Reckitt Benckiser Group Plc. OTC Cold and Cough Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Reckitt Benckiser Group Plc. OTC Cold and Cough Medicines Product Portfolio
  42. 8.7.5 Reckitt Benckiser Group Plc. Recent Developments
  43. 8.8 Procter & Gamble Co.
  44. 8.8.1 Procter & Gamble Co. Company Information
  45. 8.8.2 Procter & Gamble Co. Business Overview
  46. 8.8.3 Procter & Gamble Co. OTC Cold and Cough Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Procter & Gamble Co. OTC Cold and Cough Medicines Product Portfolio
  48. 8.8.5 Procter & Gamble Co. Recent Developments
  49. 8.9 Prestige Brands Holdings, Inc.
  50. 8.9.1 Prestige Brands Holdings, Inc. Company Information
  51. 8.9.2 Prestige Brands Holdings, Inc. Business Overview
  52. 8.9.3 Prestige Brands Holdings, Inc. OTC Cold and Cough Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Prestige Brands Holdings, Inc. OTC Cold and Cough Medicines Product Portfolio
  54. 8.9.5 Prestige Brands Holdings, Inc. Recent Developments
  55. 8.10 AstraZeneca Plc.
  56. 8.10.1 AstraZeneca Plc. Company Information
  57. 8.10.2 AstraZeneca Plc. Business Overview
  58. 8.10.3 AstraZeneca Plc. OTC Cold and Cough Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AstraZeneca Plc. OTC Cold and Cough Medicines Product Portfolio
  60. 8.10.5 AstraZeneca Plc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 OTC Cold and Cough Medicines Value Chain Analysis
  2. 9.1.1 OTC Cold and Cough Medicines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 OTC Cold and Cough Medicines Production Mode & Process
  6. 9.2 OTC Cold and Cough Medicines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 OTC Cold and Cough Medicines Distributors
  9. 9.2.3 OTC Cold and Cough Medicines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst